XML 44 R31.htm IDEA: XBRL DOCUMENT v3.24.2
EMPLOYEE STOCK PLANS (Tables)
12 Months Ended
May 31, 2024
EMPLOYEE STOCK PLANS  
Compensation costs related to the Company's stock-based compensation

 

 

Year Ended May 31,

 

(In thousands, except per share data)

 

2024

 

 

2023

 

 

2022

 

Cost of sales

 

$330

 

 

$331

 

 

$234

 

Research and development

 

 

639

 

 

 

706

 

 

 

968

 

Selling, general and administrative

 

 

1,549

 

 

 

1,711

 

 

 

1,721

 

Net effect on net income

 

$2,518

 

 

$2,748

 

 

$2,923

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Effect on earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

  Basic

 

$0.09

 

 

$0.10

 

 

$0.11

 

  Diluted

 

$0.09

 

 

$0.09

 

 

$0.11

 

Stock option and RSU transactions

(in thousands)

 

Available Shares for Grant

 

Balance, May 31, 2021

 

 

573

 

Additional shares reserved under the 2016 Plan

 

 

1,414

 

Options granted

 

 

(303)

RSUs granted

 

 

(1,044)

RSUs cancelled

 

 

20

 

Shares withheld for taxes and not issued

 

 

(30)

Options terminated

 

 

105

 

Balance, May 31, 2022

 

 

735

 

Options granted

 

 

(110)

RSUs granted

 

 

(674)

RSUs cancelled

 

 

60

 

Options terminated

 

 

16

 

Balance, May 31, 2023

 

 

27

 

Shares reserved under the 2023 Plan

 

 

1,500

 

Shares retired under the 2016 Plan

 

 

(95)

Options granted

 

 

(4)

RSUs granted

 

 

(221)

RSUs cancelled

 

 

144

 

Options terminated

 

 

12

 

Balance, May 31, 2024

 

 

1,363

 

Stock option transactions

 

 

Number of Shares

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term

 

 

Aggregated Intrinsic Value

 

 

 

(in thousands)

 

 

Per Share

 

 

(In Years)

 

 

(in thousands)

 

Balances, May 31, 2023

 

 

961

 

 

$3.67

 

 

 

4.02

 

 

$28,211

 

Options granted

 

 

4

 

 

 

49.21

 

 

 

 

 

 

 

 

 

Options terminated

 

 

(12)

 

 

3.78

 

 

 

 

 

 

 

 

 

Options exercised

 

 

(251)

 

 

2.51

 

 

 

 

 

 

 

 

 

Balances, May 31, 2024

 

 

702

 

 

$4.37

 

 

 

3.26

 

 

$5,322

 

Options exercisable, May 31, 2024

 

 

536

 

 

$3.26

 

 

 

2.83

 

 

$4,512

 

Options exercisable and expected to vest

 

 

701

 

 

$4.37

 

 

 

3.26

 

 

$5,320

 

RSUs, PRSUs, restricted shares and performance restricted shares granted

 

 

Number of Shares

 

 

Weighted Average Grant Date Fair Value

 

 

Weighted Average Remaining Contractual Term

 

 

Aggregate Intrinsic Value

 

 

 

(in thousands)

 

 

Per Share

 

 

(In Years)

 

 

(in thousands)

 

Unvested, May 31, 2023

 

 

345

 

 

$6.40

 

 

 

2.35

 

 

$11,392

 

Granted (1)

 

 

205

 

 

 

31.36

 

 

 

 

 

 

 

 

 

Vested

 

 

(170)

 

 

9.31

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(86)

 

 

13.63

 

 

 

 

 

 

 

 

 

Unvested, May 31, 2024

 

 

294

 

 

$20.08

 

 

 

2.29

 

 

$3,381

 

Fair value assumptions for Option Valuation Model

 

 

Year Ended May 31,

 

 

 

2024

 

 

2023

 

 

2022

 

 

 

 

 

 

 

 

 

 

 

Expected term (in years)

 

 

5

 

 

5-6

 

 

5-6

 

Volatility

 

 

93%

 

 

86%

 

 

88%

Risk-free interest rates

 

 

4.34%

 

 

3.12%

 

 

1.50%

Weighted average grant date fair value

 

$36.02

 

 

$6.29

 

 

$4.01

 

Fair value assumption of the ESPP Purchase Rights

 

 

Year Ended May 31,

 

 

 

2024

 

 

2023

 

 

2022

 

 

 

 

 

 

 

 

Expected term (in years)

 

0.5 – 2.0

 

 

0.5 – 2.0

 

 

0.5 – 2.0

 

Volatility

 

70% – 94

%

 

91% – 203

 

101% – 272

Risk-free interest rates

 

4.72%–5.53

%

 

3.97%–4.94

 

0.05%–2.44

Weighted average grant date fair value

 

$6.30

 

 

$13.60

 

 

$9.68